Company intelligence / Profile preview

New Pharma License Holdings

Malta

Ownership: Private
Development stage: Other

Overview

New Pharma License Holdings Ltd is involved in licensing agreements related to pharmaceutical assets. The company granted a license to Everest Medicines II Limited to develop and commercialize the antibiotic compound SPR206 in certain territories.

Industry: Drug Discovery Services

Partnerships

Everest Medicines II LimitedSpero Potentiator, Inc.

Beyond the preview

Go deeper on New Pharma License Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on New Pharma License Holdings.

Explore the full profile